117 related articles for article (PubMed ID: 32729728)
21. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
Khattab IS; Nada A; Zaghloul AA
Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
[TBL] [Abstract][Full Text] [Related]
22. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
23. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions.
Law D; Krill SL; Schmitt EA; Fort JJ; Qiu Y; Wang W; Porter WR
J Pharm Sci; 2001 Aug; 90(8):1015-25. PubMed ID: 11536205
[TBL] [Abstract][Full Text] [Related]
25. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
26. [Effect of stability and dissolution of realgar nano-particles using solid dispersion technology].
Guo T; Shi F; Yang G; Feng NP
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2782-7. PubMed ID: 24380298
[TBL] [Abstract][Full Text] [Related]
27. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole.
Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ
Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450
[TBL] [Abstract][Full Text] [Related]
28. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
30. An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.
Yan HM; Zhang ZH; Jiang YR; Ding DM; Sun E; Jia XB
Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S311-7. PubMed ID: 24991109
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
[TBL] [Abstract][Full Text] [Related]
32. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2012 Jul; 9(4):395-404. PubMed ID: 22640037
[TBL] [Abstract][Full Text] [Related]
33. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
34. Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation.
Eedara BB; Nyavanandi D; Narala S; Veerareddy PR; Bandari S
Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33673703
[TBL] [Abstract][Full Text] [Related]
35. Characterization, Molecular Docking, and In Vitro Dissolution Studies of Solid Dispersions of 20(S)-Protopanaxadiol.
Zhang Q; Pu Y; Wang B; Wang Y; Dong TT; Guo T; Zhang T; Cai Z
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208662
[TBL] [Abstract][Full Text] [Related]
36. Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration.
Deng L; Wang Y; Gong T; Sun X; Zhang ZR
Drug Dev Ind Pharm; 2017 Nov; 43(11):1817-1826. PubMed ID: 28665158
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
38. Combined application of mixture experimental design and artificial neural networks in the solid dispersion development.
Medarević DP; Kleinebudde P; Djuriš J; Djurić Z; Ibrić S
Drug Dev Ind Pharm; 2016; 42(3):389-402. PubMed ID: 26065534
[TBL] [Abstract][Full Text] [Related]
39. Self dispersing mixed micelles forming systems for enhanced dissolution and intestinal permeability of hydrochlorothiazide.
Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
Colloids Surf B Biointerfaces; 2017 Jan; 149():206-216. PubMed ID: 27768910
[TBL] [Abstract][Full Text] [Related]
40. Factors Affecting the Dissolution of Indomethacin Solid Dispersions.
Zhang W; Zhang CN; He Y; Duan BY; Yang GY; Ma WD; Zhang YH
AAPS PharmSciTech; 2017 Nov; 18(8):3258-3273. PubMed ID: 28584898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
